Menopausal Disorder Treatment Market, By Stages (Menopause, Post menopause, Perimenopause), Type (Hormonal Therapy and Non- Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression), Dosage Form (Tablet, Cream, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray), Route of Administration (Oral, Vaginal, Transdermal, Parenteral), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories), Distribution Channel (Direct Tender, Retail Sales), by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Market Size and Growth, Global Forecast to 2032

Segmentation

• The report provides detailed insights into the Global Menopausal Disorder Treatment Market, which is segmented by stages, type, symptoms, dosage form, route of administration, end-users, and distribution channels
• The stages market consists of perimenopause, menopause, and post menopause:
  • Perimenopause refers to the transition period leading up to menopause when a woman's ovaries start producing less estrogen. During this stage, a woman may experience irregular periods, hot flashes, mood swings, and other symptoms.
  • Menopause is defined as the point in time when a woman has gone 12 consecutive months without menstruating. At this stage, the ovaries stop producing eggs and the body produces less estrogen and progesterone, leading to a range of symptoms such as hot flashes, night sweats, vaginal dryness, and mood changes.
  • Post menopause refers to the period of time after menopause, which typically begins around age 51. At this stage, the symptoms of menopause may continue, but many women also experience new health concerns such as an increased risk of osteoporosis, heart disease, and urinary incontinence. Hormone therapy may still be an option for some women, but it is typically used at a lower dose and for a shorter duration than during the perimenopause and menopause stages.
• The type market consists of hormonal therapy and non- hormonal therapy:
  • Hormonal therapy, also known as hormone replacement therapy (HRT), is a type of medical treatment used to relieve symptoms of menopause. Hormonal therapy involves taking medications that contain female hormones, such as estrogen and progesterone, which the body produces less of during menopause. The therapy can be administered orally, trans dermally (through a patch), or vaginally.
  • Non-hormonal therapy, also known as alternative or complementary therapy, is a type of treatment that uses non-hormonal methods to relieve menopause symptoms. Non-hormonal therapies include herbal supplements, acupuncture, cognitive behavioral therapy, and lifestyle modifications such as regular exercise and a healthy diet. Non-hormonal therapy is often used as an alternative for women who are unable to take hormonal therapy due to personal preferences or medical conditions.
• The symptom market consists of vasomotor symptoms, atrophic vaginitis, osteoporosis, joint pain, weight gain, dyspareunia, depression, and others:
  • Vasomotor Symptoms: These refer to the hot flashes and night sweats experienced by women during menopause. They are caused by the hormonal changes that occur during menopause, and can be accompanied by other symptoms like heart palpitations and anxiety.
  • Atrophic Vaginitis: This is a condition that occurs due to the thinning and inflammation of the vaginal walls caused by the decrease in estrogen levels during menopause. It can cause symptoms like vaginal dryness, itching, and painful intercourse.
  • Osteoporosis: This is a condition where the bones become weak and brittle, increasing the risk of fractures. It occurs due to the loss of bone density, which is often accelerated during menopause due to the decrease in estrogen levels.
  • Joint Pain: Many women experience joint pain and stiffness during menopause, which can be caused by the hormonal changes and inflammation in the body. The pain is often concentrated in the hands, wrists, and knees.
  • Weight Gain: Women often experience weight gain during menopause due to a combination of factors, including decreased metabolism, hormonal changes, and lifestyle factors like decreased physical activity.
  • Dyspareunia: This refers to pain during intercourse, which can be caused by a variety of factors including vaginal dryness, inflammation, and thinning of the vaginal walls.
  • Depression: Depression is a mood disorder characterized by feelings of sadness, hopelessness, and loss of interest in activities. It can be triggered or exacerbated by the hormonal changes and stressors associated with menopause.
  • Other symptoms include fatigue, urinary incontinence and insomnia
• The dosage form market consists of tablet, cream, gels, rings/insert, patch/film, injection shot, spray, and others:
  • Tablets are oral medications that are ingested and dissolve in the stomach to release the active ingredient.
  • Creams are a topical dosage form that is applied to the skin. They typically contain a mixture of active and inactive ingredients and are designed to be absorbed through the skin.
  • Gels are similar to creams in that they are a topical dosage form applied to the skin. However, gels typically have a higher water content and are more easily absorbed than creams
  • Sprays are a dosage form that is administered as a fine mist through a nozzle or pump. Some sprays may contain hormones or other active ingredients, while others may contain natural or herbal remedies.
  • Rings/inserts are a type of vaginal medication that is placed inside the vagina and slowly releases the active ingredient over time.
  • Patch/film is a type of transdermal medication that is applied to the skin and releases the active ingredient over time through the skin.
  • Injection shot is an intramuscular or subcutaneous injection of medication that provides systemic relief to symptoms.
  • Other dosage forms include sublingual tablets, buccal tablets, and suppositories
• The route of administration market consists of oral, vaginal, transdermal, and parenteral:
  • Oral: Oral route of administration involves taking medications by mouth. Hormonal therapy drugs, such as estrogen and progesterone, are often administered orally in the form of tablets or capsules.
  • Vaginal: Vaginal route of administration involves delivering medications directly into the vagina. Vaginal estrogen therapy is a common treatment for vaginal atrophy and dryness during menopause. It can be administered in the form of vaginal tablets, creams, rings, or suppositories.
  • Transdermal: Transdermal route of administration involves applying medications to the skin, which then get absorbed into the bloodstream. Transdermal patches are commonly used for hormone replacement therapy (HRT) during menopause. The patch is applied to the skin and releases a consistent dose of hormones over time.
  • Parenteral: Parenteral route of administration involves delivering medications directly into the bloodstream. This can be done through injections, such as subcutaneous or intramuscular injections. Injections of progesterone and testosterone are sometimes used as a part of hormone therapy during menopause.
• The end-user market consists of hospital/clinical laboratories, physician offices, reference laboratories and other end-users:
  • Hospital/Clinical Laboratories are medical facilities that provide inpatient and outpatient care to patients. These facilities often have specialized units and equipment to provide care to patients with various conditions. They may administer menopausal disorder treatments to patients who are admitted to the hospital or receiving outpatient care.
  • Physician Offices are facilities where medical doctors provide primary and specialty care to patients. They may prescribe and administer menopausal disorder treatments to patients who visit their offices for check-ups, consultations, or specific treatments.
  • Reference Laboratories are medical facilities that provide diagnostic and laboratory testing services to healthcare providers. They may receive samples of blood, urine, or other bodily fluids from patients to test for the presence of certain conditions or diseases. They may also test the effectiveness of menopausal disorder treatments that patients are receiving.
  • Other end-users of menopausal disorder treatment include fertility clinics and menopause clinics. Fertility clinics provide specialized treatment for women who are experiencing menopause-related infertility issues. Menopause clinics provide a comprehensive range of menopause-related services, including diagnosis, treatment, and counseling.
• The distribution channel market consists of direct tender, retail sales and other:
  • Direct Tender: This channel involves the procurement of products directly from the manufacturer or authorized distributors. This channel is commonly used by hospitals, clinics, and other healthcare facilities that have established relationships with manufacturers or authorized distributors.
  • Retail Sales: This channel involves the sale of products through retail outlets such as pharmacies, drugstores, and supermarkets. This channel is commonly used by consumers who purchase menopausal disorder treatment products over-the-counter.
  • Other methods of distribution include online sales, mail-order, and home delivery services. This channel is becoming increasingly popular with the rise of e-commerce and the growing preference for online shopping among consumers.

Methodology